Chimerix Inc. diskutieren
Chimerix Inc.
WKN: A1T65B / Symbol: CMRX / Name: Chimerix / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
0,77 €
-1,28 %
Chimerix, Inc. (NASDAQ: CMRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Ratings data for CMRX provided by MarketBeat
Chimerix, Inc. (NASDAQ: CMRX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock.
Ratings data for CMRX provided by MarketBeat
Chimerix, Inc. (NASDAQ: CMRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Ratings data for CMRX provided by MarketBeat
Chimerix, Inc. (NASDAQ: CMRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
Ratings data for CMRX provided by MarketBeat
Chimerix, Inc. (NASDAQ: CMRX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CMRX provided by MarketBeat
Chimerix, Inc. (NASDAQ: CMRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.
Ratings data for CMRX provided by MarketBeat
Chimerix, Inc. (NASDAQ: CMRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.
Ratings data for CMRX provided by MarketBeat
Neueste Beiträge
EF_Hutton_Acquisitio in Immunic Inc. diskutieren